Literature DB >> 1618835

Kinetics of colchicine binding to purified beta-tubulin isotypes from bovine brain.

A Banerjee1, R F Luduena.   

Abstract

Tubulin, the constituent protein of microtubules, is an alpha beta heterodimer; both alpha and beta exist in several isotypic forms whose functional significance is not precisely known. The antimitotic alkaloid colchicine binds to mammalian brain tubulin in a biphasic manner under pseudo-first-order conditions in the presence of a large excess of colchicine (Garland, D. L. (1978) Biochemistry 17, 4266-4272). We have studied the kinetics of colchicine binding to purified beta-tubulin isotypes and find that each of the purified beta-tubulin isotypes binds colchicine in a monophasic manner. The apparent on-rate constants for the binding of colchicine to alpha beta II-, alpha beta III-, and alpha beta IV-tubulin dimers are respectively 132 +/- 5, 30 +/- 2, and 236 +/- 7 M-1 s-1. When the isotypes are mixed, the kinetics become biphasic. Scatchard analysis revealed that the isotypes differ significantly in their affinity constants (Ka) for binding colchicine. The affinity constants are 0.24 x 10(6), 0.12 x 10(6), and 3.31 x 10(6) M-1, respectively, for alpha beta II-, alpha beta III-, and alpha beta IV-tubulin dimers. Our results are in agreement with the hypothesis that the beta-subunit of tubulin plays a major role in the interaction of colchicine with tubulin. Our binding data raise the possibility that the tubulin isotypes might play important regulatory roles by interacting differently with other non-tubulin proteins in vivo, which in turn, may regulate microtubule-based functions in living cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine site.

Authors:  R M Hartley; J Peng; G A Fest; S Dakshanamurthy; D E Frantz; M L Brown; S L Mooberry
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  Concentration dependence of variability in growth rates of microtubules.

Authors:  Susan Pedigo; Robley C Williams
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

3.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

Review 4.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

5.  Characterization of the colchicine binding site on avian tubulin isotype betaVI.

Authors:  Shubhada Sharma; Barbara Poliks; Colby Chiauzzi; Rudravajhala Ravindra; Adam R Blanden; Susan Bane
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

6.  Biphasic kinetics of the colchicine-tubulin interaction: role of amino acids surrounding the A ring of bound colchicine molecule.

Authors:  Suvroma Gupta; Mithu Banerjee; Asim Poddar; Asok Banerjee; Gautam Basu; Debjani Roy; Bhabatarak Bhattacharyya
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

7.  Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin.

Authors:  Antonella Pepe; Liang Sun; Ilaria Zanardi; Xinyuan Wu; Cristiano Ferlini; Gabriele Fontana; Ezio Bombardelli; Iwao Ojima
Journal:  Bioorg Med Chem Lett       Date:  2009-04-22       Impact factor: 2.823

8.  Characterization of trifluralin binding with recombinant tubulin from Trypanosoma brucei.

Authors:  Natalie L Giles; Anthony Armson; Simon A Reid
Journal:  Parasitol Res       Date:  2008-12-03       Impact factor: 2.289

9.  Mechanism of tubulin-colchicine recognition: a kinetic study of the binding of the colchicine analogues colchicide and isocolchicine.

Authors:  C Dumortier; Q Yan; S Bane; Y Engelborghs
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

10.  Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.

Authors:  Weiwei Wang; Hangxiao Zhang; Xumin Wang; Jordan Patterson; Philip Winter; Kathryn Graham; Sunita Ghosh; John C Lee; Christos D Katsetos; John R Mackey; Jack A Tuszynski; Gane Ka-Shu Wong; Richard F Ludueña
Journal:  Protoplasma       Date:  2016-12-09       Impact factor: 3.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.